Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Reinhard, Rosinke"'
Autor:
Rama Shanker Verma, Janendra K. Batra, Stefan Barth, Reinhard Rosinke, Alessa Pardo, Swati Choudhary
Publikováno v:
Applied Microbiology and Biotechnology. 100:263-277
Autocrine activation of c-kit (KIT receptor tyrosine kinase) has been postulated to be a potent oncogenic driver in small cell lung cancer, neuroblastoma (NB), and poorly differentiated colorectal carcinoma (CRC). Although targeted therapy involving
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7162f7b5ffdbb5ea866f44f0aebf09a7
https://doi.org/10.1007/s00253-015-6978-2
https://doi.org/10.1007/s00253-015-6978-2
Autor:
Stefan Barth, Edgar Jost, Theo Thepen, Grit Hehmann-Titt, Sonja Schiffer, Georg Melmer, Michael Huhn, Reinhard Rosinke
Publikováno v:
International Journal of Cancer. 135:1497-1508
CMML (chronic myelomonocytic leukemia) belongs to the group of myeloid neoplasms known as myelodysplastic and myeloproliferative diseases. In some patients with a history of CMML, the disease transforms to acute myelomonocytic leukemia (AMML). There
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f1d4ae54898d6f809af10e24dd8d4fd
https://doi.org/10.1002/ijc.28786
https://doi.org/10.1002/ijc.28786
Autor:
Sonja, Schiffer, Reinhard, Rosinke, Edgar, Jost, Grit, Hehmann-Titt, Michael, Huhn, Georg, Melmer, Stefan, Barth, Theo, Thepen
Publikováno v:
International journal of cancer. 135(6)
CMML (chronic myelomonocytic leukemia) belongs to the group of myeloid neoplasms known as myelodysplastic and myeloproliferative diseases. In some patients with a history of CMML, the disease transforms to acute myelomonocytic leukemia (AMML). There
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2214f43254ab68e9e4e3c14462c57c69
https://pubmed.ncbi.nlm.nih.gov/24523193
https://pubmed.ncbi.nlm.nih.gov/24523193
Autor:
Stefan Barth, T. Thepen, Edgar Jost, Michael Stöcker, Reinhard Rosinke, Rainer Fischer, Bettina Stahnke, Mehmet Kemal Tur
Publikováno v:
Molecular cancer therapeutics. 7(9)
Acute myeloid leukemia (AML) cells of subtypes M4 and M5 show enhanced expression of CD64 (FcγRI), the high-affinity receptor for IgG, which is normally expressed at high levels only on activated cells of the myeloid lineage. CD64 is therefore a pri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f633f7b5070a0f62f7de8a8cf6392c4f
https://pubmed.ncbi.nlm.nih.gov/18790773
https://pubmed.ncbi.nlm.nih.gov/18790773
Autor:
Alessa Pardo, Janendra K. Batra, Swati Choudhary, Stefan Barth, Reinhard Rosinke, Rama Shanker Verma
Publikováno v:
Molecular Cancer Therapeutics. 12:B240-B240
Currently, the treatment options for patients with neuroendocrine carcinomas (NECs) are limited. Stem cell factor is found to have a trophic role in neuroendocrine cancer cells through an autocrine growth loop, which leads to the activation of the c-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::68acad7066c106a739334b0b069fd4a1
https://doi.org/10.1158/1535-7163.targ-13-b240
https://doi.org/10.1158/1535-7163.targ-13-b240